In Europe, the supply of the new coronavirus vaccine from pharmaceutical companies has been delayed, and the Italian government has shown its willingness to take legal action against pharmaceutical companies, and each country is frustrated.

In the EU-European Union, vaccinations developed by American pharmaceutical giant Pfizer and German Biontech began last month, but according to the researchers' website, at least once in the region as of the 24th. Citizens are less than 2%.



While EU countries have pointed out that the supply of vaccines from pharmaceutical companies is delayed, Pfizer and others are changing the process at the Belgian base where vaccines are produced as production expands. It explains that the supply is temporarily decreasing.



In addition, the EU is expected to issue a license for the vaccine of British pharmaceutical giant AstraZeneca soon, but AstraZeneca also commented that the initial supply will be lower than planned, and the EU contracted with the company on the 24th. I sent a letter urging the supply as it is.



Italy's Foreign Minister Dimaio said on the local television on the 24th that he would "do everything possible to fulfill the contract" and showed a willingness to take legal action against pharmaceutical companies. EU countries are getting frustrated as the alleged mutant virus spreads.

Britain is also concerned about vaccine supply

In the United Kingdom, where the spread of mutated viruses is serious, vaccination is progressing at a rapid pace, with more than 6.5 million people receiving the first vaccination so far, and about 78% of the elderly over 80 years old. It means that I was vaccinated.



The government is aiming to inoculate 15 million people, including residents and staff of facilities for the elderly, elderly people aged 70 and over, and medical staff by the 15th of next month, and has been doing well so far. I am supposed to be.



However, the British government has often expressed concern about the supply of vaccines, and Health Minister Hancock said at a press conference on the 25th that "there is no room for vaccine supply" to proceed with vaccination as planned. , Reemphasized the view that supply will be a major issue.